world

Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?

Is Johnson & Johnson’s $5.5 Billion Talc Settlement a Buy Signal, or Is the Legal Risk Far From Over?

UK productivity showing sustained improvement, economists say

Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?

Walmart Fell 9%. I’m Not Sure This Is Just a Walmart Problem

Looking for help with today's NYT Strands puzzle? Here's an extra hint to help you uncover the right words, as well as all of today's answers and Spangram.

Micron CEO is doubling down on a cycle-free future

Danaher vs. Medtronic: Which Healthcare Recovery Story Has More Upside?

England’s top-flight Premier League promises another exciting campaign this season.

Japan’s stock market setup looks similar to late 2023. Here’s what it means